Maltol ameliorates intervertebral disc degeneration through inhibiting PI3K/AKT/NF-κB pathway and regulating NLRP3 inflammasome-mediated pyroptosis.
Yuhang GongJianxing QiuTing JiangZe LiWeikang ZhangXiaohang ZhengZixuan HeWeifu ChenZhangfu WangXingbing FengMeizhen WangZheng-Hua HongPublished in: Inflammopharmacology (2022)
Our results suggest that MA slowed IDD development through the PI3K/AKT/NF-κB signaling pathway and NLRP3 inflammasome-mediated pyroptosis, indicating that MA appeared to be a viable medication for IDD treatment.